Mastocytosis
| 40 | Maurer, M. and Siebenhaar, F.: Mastocytosis. In: Plewig, G., Landthaler, M., Burgdorf, W., Hertl, M. and Ruzicka, T., editors: Braun-Falco’s Dermatology. 4. ed., Heidelberg: Springer, 2020. |
bc.40
Results
Found 412 hits.
Search Results for: H19-423_V1.0 Latest Test Testking 🍀 H19-423_V1.0 Practical Information 📄 H19-423_V1.0 Test Price 🕔 Go to website ☀ www.pdfvce.com ️☀️ open and search for ➠ H19-423_V1.0 🠰 to download for free 🎤H19-423_V1.0 Download Pdf – Page 37
Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands
| 74 | Mrabet-Dahbi, S., Metz, M., Dudeck, A., Zuberbier, T., and Maurer, M.+: Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp. Dermatol. 2009: 18; 437-444. IF: 3.24 |
o.074
Characterization of prodromal symptoms in a large population of patients with hereditary angioedema
| 182 | Magerl, M.+, Doumoulakis, G., Kalkounou, I., Weller, K., Church, M. K., Kreuz, W., and Maurer, M.:Characterization of prodromal symptoms in a large population of patients with hereditary angioedema. Clin. Exp. Dermatol. 2014: 39; 298-303. IF: 1.09 |
Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor–patient relation
| 77 | Maurer, M.+ Ortonne, J.-P., and Zuberbier, T.: Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy 2009: 64; 581-588. IF: 6.38 |
Physical urticaria
| 62. | Abajian, M., Młynek, A., and Maurer, M.: Physical urticaria. Curr. Allergy Asthma Rep. 2012: 12; 281-287. IF: 2.74 |
Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria
| 188 | Kay, A. B.+, Ying, S., Ardelean, E., Młynek, A., Kita, H., Clark, P., and Maurer, M.: Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria. Clin. Exp. Allergy 2014: 44; 1053-1060. IF: 4.77 |
Immunoglobulin E-mediated autoimmunity
| 134. | Maurer, M., Altrichter, S., Schmetzer, O., Scheffel, J., Church, M. K.+, and Metz, M.: Immunoglobulin E-mediated autoimmunity. Front. Immunol. 2018: 9; 689. IF: 4.72 |
Antihistamines in the Treatment of Urticaria
| 54. | Zuberbier, T. and Maurer, M.: Antihistamines in the treatment of urticaria. Adv. Exp. Med. Biol. 2011: 709; 67-72. IF: 1.37 |
Mast cells drivers of disease and therapeutic targets
| 132. | Siebenhaar, F., Redegeld, F. A., Bischoff, S. C., Gibbs, B. F., and Maurer, M.+: Mast cells drivers of disease and therapeutic targets. Trends Immunol. 2018: 39; 151-162. IF: 13.00 |
Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine
| 194 | Hiraoka, K., Tashiro, M., Grobosch, T., Maurer, M. Oda, K., Toyohara, J., Ishii, K., Ishiwata, K., and Yanai, K.+: Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine. Expert Opin. Drug. Saf. 2014: 14; 1-8. IF: 2.91 |